About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Expanding Price Control Detrimental for Pharma Companies: CII

by Medindia Content Team on July 19, 2006 at 12:53 PM
Font : A-A+

Expanding Price Control Detrimental for Pharma Companies: CII

Expressing concern over the proposal to expand price control from 74 to 354 drugs in the proposed national pharmaceutical policy, industry chamber CII today said the step will prove detrimental to the growth of the industry as well as the economy.

"Healthy competition between pharma companies already ensures reasonable pricing. Instead of affecting the growth by over regulation, it would be better to allow market forces to determine prices," CII's National Committee on Drugs and Pharmaceuticals Chairman Ajay Piramal told reporters after a meeting with the committee members here.

Advertisement

The committee suggested that the government should maintain 'status quo' on the current 74 bulk drugs under cost based price control and effective monitoring of the National List of Essential Medicines (NLEM) drugs to control any abnormal price increase.

It also proposed to allow government agencies to procure at a ceiling price of 50 per cent of MRP voluntarily and provide adequate incentives for R&D oriented Indian companies.
Advertisement

"Any sudden regulatory shocks like increased price contro would be detrimental to the industry and the economy," Piramal said.

Quoting independent studies, Piramal said that there had been an average five per cent decline in real terms over the last four years and drug prices in India are among the lowest in the world.

He pointed out that product patent regime will impact the industry leading to higher investment requirement for R&D.

"Large investments in R&D are critical for affordable medicines in the future," he said.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Most Popular on Medindia

Blood - Sugar Chart A-Z Drug Brands in India Daily Calorie Requirements Accident and Trauma Care Pregnancy Confirmation Calculator Post-Nasal Drip Indian Medical Journals Color Blindness Calculator Hearing Loss Calculator Calculate Ideal Weight for Infants
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Expanding Price Control Detrimental for Pharma Companies: CII Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests